BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33007388)

  • 1. Nr2e3 functional domain ablation by CRISPR-Cas9D10A identifies a new isoform and generates retinitis pigmentosa and enhanced S-cone syndrome models.
    Aísa-Marín I; López-Iniesta MJ; Milla S; Lillo J; Navarro G; de la Villa P; Marfany G
    Neurobiol Dis; 2020 Dec; 146():105122. PubMed ID: 33007388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Data on the generation of two
    Aísa-Marín I; López-Iniesta MJ; Marfany G
    Data Brief; 2020 Dec; 33():106447. PubMed ID: 33163596
    [No Abstract]   [Full Text] [Related]  

  • 3. Modifier genes as therapeutics: the nuclear hormone receptor Rev Erb alpha (Nr1d1) rescues Nr2e3 associated retinal disease.
    Cruz NM; Yuan Y; Leehy BD; Baid R; Kompella U; DeAngelis MM; Escher P; Haider NB
    PLoS One; 2014; 9(1):e87942. PubMed ID: 24498227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential dimerization of variants linked to enhanced S-cone sensitivity syndrome (ESCS) located in the NR2E3 ligand-binding domain.
    von Alpen D; Tran HV; Guex N; Venturini G; Munier FL; Schorderet DF; Haider NB; Escher P
    Hum Mutat; 2015 Jun; 36(6):599-610. PubMed ID: 25703721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New truncation mutation of the NR2E3 gene in a Japanese patient with enhanced S-cone syndrome.
    Kuniyoshi K; Hayashi T; Sakuramoto H; Mishima H; Tsuneoka H; Tsunoda K; Iwata T; Shimomura Y
    Jpn J Ophthalmol; 2016 Nov; 60(6):476-485. PubMed ID: 27522502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NR2E3 mutations in enhanced S-cone sensitivity syndrome (ESCS), Goldmann-Favre syndrome (GFS), clumped pigmentary retinal degeneration (CPRD), and retinitis pigmentosa (RP).
    Schorderet DF; Escher P
    Hum Mutat; 2009 Nov; 30(11):1475-85. PubMed ID: 19718767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of NR2E3 Associated Enhanced S-cone Syndrome Patient-specific iPSCs using CRISPR-Cas9.
    Bohrer LR; Wiley LA; Burnight ER; Cooke JA; Giacalone JC; Anfinson KR; Andorf JL; Mullins RF; Stone EM; Tucker BA
    Genes (Basel); 2019 Apr; 10(4):. PubMed ID: 30959774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allele-Specific Knockout by CRISPR/Cas to Treat Autosomal Dominant Retinitis Pigmentosa Caused by the G56R Mutation in NR2E3.
    Diakatou M; Dubois G; Erkilic N; Sanjurjo-Soriano C; Meunier I; Kalatzis V
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peculiar fundus abnormalities and pathognomonic electrophysiological findings in a 14-month-old boy with NR2E3 mutations.
    Cassiman C; Spileers W; De Baere E; de Ravel T; Casteels I
    Ophthalmic Genet; 2013; 34(1-2):105-8. PubMed ID: 23039133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and molecular characterization of enhanced S-cone syndrome in children.
    Hull S; Arno G; Sergouniotis PI; Tiffin P; Borman AD; Chandra A; Robson AG; Holder GE; Webster AR; Moore AT
    JAMA Ophthalmol; 2014 Nov; 132(11):1341-9. PubMed ID: 25079116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nuclear receptor NR2E3 plays a role in human retinal photoreceptor differentiation and degeneration.
    Milam AH; Rose L; Cideciyan AV; Barakat MR; Tang WX; Gupta N; Aleman TS; Wright AF; Stone EM; Sheffield VC; Jacobson SG
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):473-8. PubMed ID: 11773633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo analysis of onset and progression of retinal degeneration in the Nr2e3
    Venturini G; Kokona D; Steiner BL; Bulla EG; Jovanovic J; Zinkernagel MS; Escher P
    Sci Rep; 2021 Sep; 11(1):19032. PubMed ID: 34561487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-color pupillometry in enhanced S-cone syndrome caused by NR2E3 mutations.
    Collison FT; Park JC; Fishman GA; Stone EM; McAnany JJ
    Doc Ophthalmol; 2016 Jun; 132(3):157-66. PubMed ID: 27033713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the DNA-binding domain of NR2E3 affect in vivo dimerization and interaction with CRX.
    Roduit R; Escher P; Schorderet DF
    PLoS One; 2009 Oct; 4(10):e7379. PubMed ID: 19823680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of the human cone photoreceptor mosaic from a defect in NR2E3 transcription factor function in young adults.
    Park SP; Hong IH; Tsang SH; Lee W; Horowitz J; Yzer S; Allikmets R; Chang S
    Graefes Arch Clin Exp Ophthalmol; 2013 Oct; 251(10):2299-309. PubMed ID: 23604511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shared mutations in NR2E3 in enhanced S-cone syndrome, Goldmann-Favre syndrome, and many cases of clumped pigmentary retinal degeneration.
    Sharon D; Sandberg MA; Caruso RC; Berson EL; Dryja TP
    Arch Ophthalmol; 2003 Sep; 121(9):1316-23. PubMed ID: 12963616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological verification of enhanced S-cone syndrome caused by a novel c.755T>C NR2E3 missense variant.
    Cehajic-Kapetanovic J; Cottriall CL; Jolly JK; Shanks M; Clouston P; Charbel Issa P; MacLaren RE
    Ophthalmic Genet; 2019 Feb; 40(1):29-33. PubMed ID: 30466340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Pathogenic Sequence Variants in
    Al-Khuzaei S; Broadgate S; Halford S; Jolly JK; Shanks M; Clouston P; Downes SM
    Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33138239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotype Driven Analysis of Whole Genome Sequencing Identifies Deep Intronic Variants that Cause Retinal Dystrophies by Aberrant Exonization.
    Di Scipio M; Tavares E; Deshmukh S; Audo I; Green-Sanderson K; Zubak Y; Zine-Eddine F; Pearson A; Vig A; Tang CY; Mollica A; Karas J; Tumber A; Yu CW; Billingsley G; Wilson MD; Zeitz C; Héon E; Vincent A
    Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):36. PubMed ID: 32881472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cone Vision Changes in the Enhanced S-Cone Syndrome Caused by NR2E3 Gene Mutations.
    Garafalo AV; Calzetti G; Cideciyan AV; Roman AJ; Saxena S; Sumaroka A; Choi W; Wright AF; Jacobson SG
    Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3209-3219. PubMed ID: 29971438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.